China Bicalutamide Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Bicalutamide market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Bicalutamide market. Detailed analysis of key players, along with key growth strategies adopted by Bicalutamide industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sorres Pharma

    • ANI Pharmaceuticals

    • Zeneca GmbH

    • CORDEN PHARMA GMBH

    • Zhejiang Haizheng Pharmaceutical

    • Fresenius Kabi

    • Shanghai Zhaohui Pharmaceutical

    • Sivem Pharmaceuticals

    • Accel Pharma

    • Actavis Pharma

    • AstraZeneca

    • Shanghai Fudan Fuhua Pharmaceutical

    • Shanxi Zhendong Pharmaceutical

    • Apotex Corporation

    By Type:

    • Tablets

    • Capsule

    By End-User:

    • Single Drug For Prostate Cancer

    • Combined Chemotherapy For Prostate Cancer

    • Combined Radiation Therapy Or Castration For Prostate Cancer

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Bicalutamide Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Bicalutamide Market Size and Growth Rate of Tablets from 2016 to 2027

    • 1.3.2 China Bicalutamide Market Size and Growth Rate of Capsule from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Bicalutamide Market Size and Growth Rate of Single Drug For Prostate Cancer from 2016 to 2027

    • 1.4.2 China Bicalutamide Market Size and Growth Rate of Combined Chemotherapy For Prostate Cancer from 2016 to 2027

    • 1.4.3 China Bicalutamide Market Size and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Bicalutamide Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Bicalutamide by Major Types

    • 3.4.1 Market Size and Growth Rate of Tablets

    • 3.4.2 Market Size and Growth Rate of Capsule

    4 Segmentation of Bicalutamide Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Bicalutamide by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Bicalutamide in Single Drug For Prostate Cancer

    • 4.4.2 Market Size and Growth Rate of Bicalutamide in Combined Chemotherapy For Prostate Cancer

    • 4.4.3 Market Size and Growth Rate of Bicalutamide in Combined Radiation Therapy Or Castration For Prostate Cancer

    5 Market Analysis by Regions

    • 5.1 China Bicalutamide Production Analysis by Regions

    • 5.2 China Bicalutamide Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Bicalutamide Landscape Analysis

    • 6.1 North China Bicalutamide Landscape Analysis by Major Types

    • 6.2 North China Bicalutamide Landscape Analysis by Major End-Users

    7 Central China Bicalutamide Landscape Analysis

    • 7.1 Central China Bicalutamide Landscape Analysis by Major Types

    • 7.2 Central China Bicalutamide Landscape Analysis by Major End-Users

    8 South China Bicalutamide Landscape Analysis

    • 8.1 South China Bicalutamide Landscape Analysis by Major Types

    • 8.2 South China Bicalutamide Landscape Analysis by Major End-Users

    9 East China Bicalutamide Landscape Analysis

    • 9.1 East China Bicalutamide Landscape Analysis by Major Types

    • 9.2 East China Bicalutamide Landscape Analysis by Major End-Users

    10 Northeast China Bicalutamide Landscape Analysis

    • 10.1 Northeast China Bicalutamide Landscape Analysis by Major Types

    • 10.2 Northeast China Bicalutamide Landscape Analysis by Major End-Users

    11 Southwest China Bicalutamide Landscape Analysis

    • 11.1 Southwest China Bicalutamide Landscape Analysis by Major Types

    • 11.2 Southwest China Bicalutamide Landscape Analysis by Major End-Users

    12 Northwest China Bicalutamide Landscape Analysis

    • 12.1 Northwest China Bicalutamide Landscape Analysis by Major Types

    • 12.2 Northwest China Bicalutamide Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Sorres Pharma

      • 13.1.1 Sorres Pharma Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 ANI Pharmaceuticals

      • 13.2.1 ANI Pharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Zeneca GmbH

      • 13.3.1 Zeneca GmbH Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 CORDEN PHARMA GMBH

      • 13.4.1 CORDEN PHARMA GMBH Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Zhejiang Haizheng Pharmaceutical

      • 13.5.1 Zhejiang Haizheng Pharmaceutical Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Fresenius Kabi

      • 13.6.1 Fresenius Kabi Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Shanghai Zhaohui Pharmaceutical

      • 13.7.1 Shanghai Zhaohui Pharmaceutical Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Sivem Pharmaceuticals

      • 13.8.1 Sivem Pharmaceuticals Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Accel Pharma

      • 13.9.1 Accel Pharma Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Actavis Pharma

      • 13.10.1 Actavis Pharma Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 AstraZeneca

      • 13.11.1 AstraZeneca Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Shanghai Fudan Fuhua Pharmaceutical

      • 13.12.1 Shanghai Fudan Fuhua Pharmaceutical Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Shanxi Zhendong Pharmaceutical

      • 13.13.1 Shanxi Zhendong Pharmaceutical Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Apotex Corporation

      • 13.14.1 Apotex Corporation Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Bicalutamide Market Size and Growth Rate of Tablets from 2016 to 2027

    • Figure China Bicalutamide Market Size and Growth Rate of Capsule from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Bicalutamide Market Size and Growth Rate of Single Drug For Prostate Cancer from 2016 to 2027

    • Figure China Bicalutamide Market Size and Growth Rate of Combined Chemotherapy For Prostate Cancer from 2016 to 2027

    • Figure China Bicalutamide Market Size and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Bicalutamide Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Bicalutamide Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Bicalutamide

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Bicalutamide by Different Types from 2016 to 2027

    • Table Consumption Share of Bicalutamide by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Tablets

    • Figure Market Size and Growth Rate of Capsule

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Bicalutamide by Different End-Users from 2016 to 2027

    • Table Consumption Share of Bicalutamide by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Single Drug For Prostate Cancer

    • Figure Market Size and Growth Rate of Combined Chemotherapy For Prostate Cancer

    • Figure Market Size and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer

    • Table China Bicalutamide Production by Regions

    • Table China Bicalutamide Production Share by Regions

    • Figure China Bicalutamide Production Share by Regions in 2016

    • Figure China Bicalutamide Production Share by Regions in 2021

    • Figure China Bicalutamide Production Share by Regions in 2027

    • Table China Bicalutamide Consumption by Regions

    • Table China Bicalutamide Consumption Share by Regions

    • Figure China Bicalutamide Consumption Share by Regions in 2016

    • Figure China Bicalutamide Consumption Share by Regions in 2021

    • Figure China Bicalutamide Consumption Share by Regions in 2027

    • Table North China Bicalutamide Consumption by Types from 2016 to 2027

    • Table North China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure North China Bicalutamide Consumption Share by Types in 2016

    • Figure North China Bicalutamide Consumption Share by Types in 2021

    • Figure North China Bicalutamide Consumption Share by Types in 2027

    • Table North China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table North China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure North China Bicalutamide Consumption Share by End-Users in 2016

    • Figure North China Bicalutamide Consumption Share by End-Users in 2021

    • Figure North China Bicalutamide Consumption Share by End-Users in 2027

    • Table Central China Bicalutamide Consumption by Types from 2016 to 2027

    • Table Central China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure Central China Bicalutamide Consumption Share by Types in 2016

    • Figure Central China Bicalutamide Consumption Share by Types in 2021

    • Figure Central China Bicalutamide Consumption Share by Types in 2027

    • Table Central China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table Central China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Bicalutamide Consumption Share by End-Users in 2016

    • Figure Central China Bicalutamide Consumption Share by End-Users in 2021

    • Figure Central China Bicalutamide Consumption Share by End-Users in 2027

    • Table South China Bicalutamide Consumption by Types from 2016 to 2027

    • Table South China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure South China Bicalutamide Consumption Share by Types in 2016

    • Figure South China Bicalutamide Consumption Share by Types in 2021

    • Figure South China Bicalutamide Consumption Share by Types in 2027

    • Table South China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table South China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure South China Bicalutamide Consumption Share by End-Users in 2016

    • Figure South China Bicalutamide Consumption Share by End-Users in 2021

    • Figure South China Bicalutamide Consumption Share by End-Users in 2027

    • Table East China Bicalutamide Consumption by Types from 2016 to 2027

    • Table East China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure East China Bicalutamide Consumption Share by Types in 2016

    • Figure East China Bicalutamide Consumption Share by Types in 2021

    • Figure East China Bicalutamide Consumption Share by Types in 2027

    • Table East China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table East China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure East China Bicalutamide Consumption Share by End-Users in 2016

    • Figure East China Bicalutamide Consumption Share by End-Users in 2021

    • Figure East China Bicalutamide Consumption Share by End-Users in 2027

    • Table Northeast China Bicalutamide Consumption by Types from 2016 to 2027

    • Table Northeast China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Bicalutamide Consumption Share by Types in 2016

    • Figure Northeast China Bicalutamide Consumption Share by Types in 2021

    • Figure Northeast China Bicalutamide Consumption Share by Types in 2027

    • Table Northeast China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table Northeast China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Bicalutamide Consumption Share by End-Users in 2016

    • Figure Northeast China Bicalutamide Consumption Share by End-Users in 2021

    • Figure Northeast China Bicalutamide Consumption Share by End-Users in 2027

    • Table Southwest China Bicalutamide Consumption by Types from 2016 to 2027

    • Table Southwest China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Bicalutamide Consumption Share by Types in 2016

    • Figure Southwest China Bicalutamide Consumption Share by Types in 2021

    • Figure Southwest China Bicalutamide Consumption Share by Types in 2027

    • Table Southwest China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table Southwest China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Bicalutamide Consumption Share by End-Users in 2016

    • Figure Southwest China Bicalutamide Consumption Share by End-Users in 2021

    • Figure Southwest China Bicalutamide Consumption Share by End-Users in 2027

    • Table Northwest China Bicalutamide Consumption by Types from 2016 to 2027

    • Table Northwest China Bicalutamide Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Bicalutamide Consumption Share by Types in 2016

    • Figure Northwest China Bicalutamide Consumption Share by Types in 2021

    • Figure Northwest China Bicalutamide Consumption Share by Types in 2027

    • Table Northwest China Bicalutamide Consumption by End-Users from 2016 to 2027

    • Table Northwest China Bicalutamide Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Bicalutamide Consumption Share by End-Users in 2016

    • Figure Northwest China Bicalutamide Consumption Share by End-Users in 2021

    • Figure Northwest China Bicalutamide Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Sorres Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorres Pharma

    • Figure Sales and Growth Rate Analysis of Sorres Pharma

    • Figure Revenue and Market Share Analysis of Sorres Pharma

    • Table Product and Service Introduction of Sorres Pharma

    • Table Company Profile and Development Status of ANI Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ANI Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of ANI Pharmaceuticals

    • Figure Revenue and Market Share Analysis of ANI Pharmaceuticals

    • Table Product and Service Introduction of ANI Pharmaceuticals

    • Table Company Profile and Development Status of Zeneca GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zeneca GmbH

    • Figure Sales and Growth Rate Analysis of Zeneca GmbH

    • Figure Revenue and Market Share Analysis of Zeneca GmbH

    • Table Product and Service Introduction of Zeneca GmbH

    • Table Company Profile and Development Status of CORDEN PHARMA GMBH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CORDEN PHARMA GMBH

    • Figure Sales and Growth Rate Analysis of CORDEN PHARMA GMBH

    • Figure Revenue and Market Share Analysis of CORDEN PHARMA GMBH

    • Table Product and Service Introduction of CORDEN PHARMA GMBH

    • Table Company Profile and Development Status of Zhejiang Haizheng Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhejiang Haizheng Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Zhejiang Haizheng Pharmaceutical

    • Figure Revenue and Market Share Analysis of Zhejiang Haizheng Pharmaceutical

    • Table Product and Service Introduction of Zhejiang Haizheng Pharmaceutical

    • Table Company Profile and Development Status of Fresenius Kabi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kabi

    • Figure Sales and Growth Rate Analysis of Fresenius Kabi

    • Figure Revenue and Market Share Analysis of Fresenius Kabi

    • Table Product and Service Introduction of Fresenius Kabi

    • Table Company Profile and Development Status of Shanghai Zhaohui Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Zhaohui Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Shanghai Zhaohui Pharmaceutical

    • Figure Revenue and Market Share Analysis of Shanghai Zhaohui Pharmaceutical

    • Table Product and Service Introduction of Shanghai Zhaohui Pharmaceutical

    • Table Company Profile and Development Status of Sivem Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sivem Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sivem Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sivem Pharmaceuticals

    • Table Product and Service Introduction of Sivem Pharmaceuticals

    • Table Company Profile and Development Status of Accel Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Accel Pharma

    • Figure Sales and Growth Rate Analysis of Accel Pharma

    • Figure Revenue and Market Share Analysis of Accel Pharma

    • Table Product and Service Introduction of Accel Pharma

    • Table Company Profile and Development Status of Actavis Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Pharma

    • Figure Sales and Growth Rate Analysis of Actavis Pharma

    • Figure Revenue and Market Share Analysis of Actavis Pharma

    • Table Product and Service Introduction of Actavis Pharma

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Shanghai Fudan Fuhua Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Fudan Fuhua Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Shanghai Fudan Fuhua Pharmaceutical

    • Figure Revenue and Market Share Analysis of Shanghai Fudan Fuhua Pharmaceutical

    • Table Product and Service Introduction of Shanghai Fudan Fuhua Pharmaceutical

    • Table Company Profile and Development Status of Shanxi Zhendong Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanxi Zhendong Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Shanxi Zhendong Pharmaceutical

    • Figure Revenue and Market Share Analysis of Shanxi Zhendong Pharmaceutical

    • Table Product and Service Introduction of Shanxi Zhendong Pharmaceutical

    • Table Company Profile and Development Status of Apotex Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex Corporation

    • Figure Sales and Growth Rate Analysis of Apotex Corporation

    • Figure Revenue and Market Share Analysis of Apotex Corporation

    • Table Product and Service Introduction of Apotex Corporation


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.